[HTML][HTML] Heat shock proteins: agents of cancer development and therapeutic targets in anti-cancer therapy

CW Yun, HJ Kim, JH Lim, SH Lee - Cells, 2019 - mdpi.com
Heat shock proteins (HSPs) constitute a large family of molecular chaperones classified by
their molecular weights, and they include HSP27, HSP40, HSP60, HSP70, and HSP90 …

Small-molecule dual inhibitors targeting heat shock protein 90 for cancer targeted therapy

X Xie, N Zhang, X Li, H Huang, C Peng, W Huang… - Bioorganic …, 2023 - Elsevier
Heat shock protein 90, also known as Hsp90, is an extensively preserved molecular
chaperone that performs a critical function in organizing various biological pathways and …

The tumour-promoting role of protein homeostasis: Implications for cancer immunotherapy

R Liang, H Tan, H Jin, J Wang, Z Tang, X Lu - Cancer Letters, 2023 - Elsevier
Protein homeostasis, an important aspect of cellular fitness that encompasses the balance of
production, folding and degradation of proteins, has been linked to several diseases of the …

KCNQ1OT1 facilitates progression of non‐small‐cell lung carcinoma via modulating miRNA‐27b‐3p/HSP90AA1 axis

Z Dong, P Yang, X Qiu, S Liang, B Guan… - Journal of cellular …, 2019 - Wiley Online Library
Abstract Long noncoding RNA KCNQ1OT1 participates in the regulation of imprinted genes
within the kcnq1 domain. But its roles in carcinogenesis and metastasis remain largely …

[HTML][HTML] The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach

D Spiegelberg, A Abramenkovs, ACL Mortensen… - Scientific reports, 2020 - nature.com
Oncogenic client-proteins of the chaperone Heat shock protein 90 (HSP90) insure unlimited
tumor growth and are involved in resistance to chemo-and radiotherapy. The HSP90 …

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

G Augello, MR Emma, A Cusimano… - … journal of cancer, 2019 - Wiley Online Library
Hepatocellular carcinoma (HCC) is a highly malignant tumor that responds very poorly to
existing therapies, most probably due to its extraordinary inter‐and intra‐tumor molecular …

[HTML][HTML] Chaperoning STAT3/5 by heat shock proteins: interest of their targeting in cancer therapy

G Jego, F Hermetet, F Girodon, C Garrido - Cancers, 2019 - mdpi.com
While cells from multicellular organisms are dependent upon exogenous signals for their
survival, growth, and proliferation, commitment to a specific cell fate requires the correct …

[HTML][HTML] SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas

E Białopiotrowicz-Data, M Noyszewska-Kania… - Cell Death & …, 2023 - nature.com
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin
lymphoma in adults, exhibiting highly heterogenous clinical behavior and complex …

TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma

Y Jing, Z Mao, J Zhu, X Ma, H Liu, F Chen - International …, 2023 - Elsevier
Background Lung adenocarcinoma (LUAD) is one of the major types of lung cancer with
high morbidity and mortality. The TRAF-interacting protein (TRAIP) is a ring-type E3 ubiquitin …

Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer

L Yu, Q Lai, L Gou, J Feng, J Yang - Journal of Drug Targeting, 2021 - Taylor & Francis
Small cell lung cancer (SCLC) is an aggressive malignant tumour which accounts for
approximately 13–15% of all newly diagnosed lung cancer cases. To date, platinum-based …